GRP, gastrin releasing peptide, 2922

N. diseases: 172; N. variants: 1
Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.020 Biomarker group BEFREE Here we investigated the potential of a novel DOTHA<sub>2</sub>-conjugated, <sup>64</sup>Cu-radiolabeled GRPR peptide antagonist, [D-Phe<sup>6</sup>-Sta<sup>13</sup>-Leu<sup>14</sup>-NH<sub>2</sub>]bombesin(6-14) (DOTHA<sub>2</sub>-PEG-RM26) to visualize prostate tumors by PET imaging. 29154145 2018
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.020 Biomarker group BEFREE 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors. 21233180 2011